EPITHELIOID SARCOMA
Clinical trials for EPITHELIOID SARCOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID SARCOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stem cell approach aims to boost immune attack on tough childhood cancers
Disease control Recruiting nowThis study tests a stem cell transplant that removes certain immune cells (alpha/beta T cells and CD19+ B cells) and adds a drug called zoledronic acid to help the donor cells fight solid tumors that have come back or not responded to treatment. It includes children and young adu…
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
New hope for tough cancers? experimental pill HH2853 enters human trials
Disease control Recruiting nowThis study tests an experimental drug called HH2853 in people with certain blood cancers (non-Hodgkin's lymphomas) or advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 254 adults will…
Matched conditions: EPITHELIOID SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 10:24 UTC
-
Last-Resort drug opens for two rare cancers
Disease control AVAILABLEThis program provides early access to ubamatamab for people with renal medullary carcinoma or epithelioid sarcoma who have no other treatment options. The drug aims to control these aggressive cancers. Eligibility is decided case by case.
Matched conditions: EPITHELIOID SARCOMA
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Rare cancer study seeks to unlock treatment secrets
Knowledge-focused Recruiting nowThis study is watching and recording what happens to 100 people with epithelioid sarcoma, a rare type of cancer. Researchers want to learn which treatments (like chemotherapy or radiation) are used and how patients respond. The goal is to gather information to help doctors make b…
Matched conditions: EPITHELIOID SARCOMA
Sponsor: Italian Sarcoma Group • Aim: Knowledge-focused
Last updated May 26, 2026 10:28 UTC
-
500 rare sarcoma patients enrolled to unlock immune secrets
Knowledge-focused Recruiting nowThis study aims to learn more about the immune system's role in rare types of sarcoma, a group of cancers. Researchers will collect medical information and tissue samples from 500 patients with these rare sarcomas. The goal is to find patterns that could lead to better treatments…
Matched conditions: EPITHELIOID SARCOMA
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 18, 2026 12:03 UTC